Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-trace').style.display = (document.getElementById('cakeErr680fc66698c68-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680fc66698c68-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-code').style.display = (document.getElementById('cakeErr680fc66698c68-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-context').style.display = (document.getElementById('cakeErr680fc66698c68-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680fc66698c68-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680fc66698c68-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 95, 'metaTitle' => 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma', 'metaKeywords' => null, 'metaDesc' => ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...', 'disp' => '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 95 $metaTitle = 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma' $metaKeywords = null $metaDesc = ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...' $disp = '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma | Im4change.org</title> <meta name="description" content=" The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Free trade deals to push up cost of medicines by Savita Varma</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p><p align="justify"><font ></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-trace').style.display = (document.getElementById('cakeErr680fc66698c68-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680fc66698c68-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-code').style.display = (document.getElementById('cakeErr680fc66698c68-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-context').style.display = (document.getElementById('cakeErr680fc66698c68-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680fc66698c68-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680fc66698c68-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 95, 'metaTitle' => 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma', 'metaKeywords' => null, 'metaDesc' => ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...', 'disp' => '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 95 $metaTitle = 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma' $metaKeywords = null $metaDesc = ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...' $disp = '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma | Im4change.org</title> <meta name="description" content=" The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Free trade deals to push up cost of medicines by Savita Varma</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p><p align="justify"><font ></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-trace').style.display = (document.getElementById('cakeErr680fc66698c68-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680fc66698c68-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-code').style.display = (document.getElementById('cakeErr680fc66698c68-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680fc66698c68-context').style.display = (document.getElementById('cakeErr680fc66698c68-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680fc66698c68-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr680fc66698c68-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 95, 'metaTitle' => 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma', 'metaKeywords' => null, 'metaDesc' => ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...', 'disp' => '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 95 $metaTitle = 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma' $metaKeywords = null $metaDesc = ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...' $disp = '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO&rsquo;s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the &rsquo;Forum Against FTAs&rsquo;, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >&quot;These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes,&quot; a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >&quot;The government refused to include some measures suggested by the EU. But it is under great pressure,&quot; the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >&quot;These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines,&quot; said the spokesperson. &quot;It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis.&quot;</font> </p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma | Im4change.org</title> <meta name="description" content=" The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Free trade deals to push up cost of medicines by Savita Varma</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p><p align="justify"><font ></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [[maximum depth reached]], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 95, 'metaTitle' => 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma', 'metaKeywords' => null, 'metaDesc' => ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...', 'disp' => '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 95, 'title' => 'Free trade deals to push up cost of medicines by Savita Varma', 'subheading' => '', 'description' => '<p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> ', 'credit_writer' => 'India Today, 6 September, 2009, http://bilaterals.org/article.php3?id_article=15852', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'free-trade-deals-to-push-up-cost-of-medicines-by-savita-varma-154', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 154, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 95 $metaTitle = 'LATEST NEWS UPDATES | Free trade deals to push up cost of medicines by Savita Varma' $metaKeywords = null $metaDesc = ' The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned. The FTAs are discussed outside...' $disp = '<p align="justify"><br /><font >The bilateral free trade agreements (FTAs) India is negotiating with Japan and the European Union (EU) can lead to a sharp rise in the cost of medicines, a network of civil society groups has warned.</font> </p><p align="justify"><font >The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement.</font> </p><p align="justify"><font >In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them.</font> </p><p align="justify"><font >The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent.</font> </p><p align="justify"><font >"These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said.</font> </p><p align="justify"><font >India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members.</font> </p><p align="justify"><font >"The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up.</font> </p><p align="justify"><font >Thailand was also considering an agreement with the US, which was not signed after fierce public opposition.</font> </p><p align="justify"><font >Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it.</font> </p><p align="justify"><font >"These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis."</font> </p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Free trade deals to push up cost of medicines by Savita Varma |
The FTAs are discussed outside the parameters of equitable international trade endorsed by the World Trade Organisation (WTO). Through them, developed countries often impose higher levels of intellectual property protection for medicines than those mandated by the WTO’s TRIPS agreement. In some cases, the terms are even harsher than those practised within the developed world, says the ’Forum Against FTAs’, a conglomeration of some 75 NGOs. It wants the government to be transparent about these deals and hold discussions with all stakeholders before committing to them. The worrying terms of the FTAs include the extension of patents beyond 20 years; data exclusivity, which delays the entry of a generic medicine in a market by 10-15 years even after the expiry of a patent; and the patent-registration linkage, which prevents the registration of a generic manufacturer before the expiry of patent. "These are all ploys to maintain the monopoly of patent holders and keep the prices high by delaying the entry of generic versions of medicines. Multinationals such as Abbot, Glaxo, Pfizer, Bayer, Roche, Sanofi and Novartis have been seeking these changes," a spokesperson of the forum said. India has already carried out 10 rounds of negotiations with Japan, six rounds with the EU and three rounds with the European Free Trade Association (EFTA), which includes Switzerland, Norway, Iceland and Lichtenstein as its members. "The government refused to include some measures suggested by the EU. But it is under great pressure," the spokesperson said. After countries like Peru and Colombia signed such agreements, the prices of medicines went up. Thailand was also considering an agreement with the US, which was not signed after fierce public opposition. Despite opposition from the Kerala government against some provisions of the FTA with ASEAN, the government went ahead with it. "These arrangements not only erode flexibilities allowed by the Doha declaration, which established superiority of public health, but also impose a number of additional obligations which can restrict access to medicines," said the spokesperson. "It is time to test the Right to Information (RTI) Act in the context of these agreements, which requires sharing of information on a proactive basis." |